1. TY-PAN-0597 Date of preparation: May 2013FOR HEALTHCARE PROFESSIONALS ONLYTYSABRI (natalizumab)Benefit/Risk Update &PML Risk Stratification 2. TY-PAN-0597 Date of…

1. Hit hard and early! Gavin GiovannoniBarts and The London School of Medicine and Dentistry XVIIIth EuropeanCharcot Foundation SymposiumMarbella , Spain 29th Nov to 1st…

1. GAVIN GIOVANNONIBARTS AND THE LONDONDefining Goals and PatientExpectations: The Importance ofEarly Planning1 2. Consequences of Increasing EDSS Scores:Loss of Employment2The…

1. Disease ModifyingTreatments:Mediocrity and then some? Dr Trevor PickersgillConsultant Neurologist University Hospital of WalesRoyal Glamorgan Hospital Hon Lecturer, Cardiff…

1. ENDOSULFAN .... 2. INTRODUCTIONOne of agricultural poisons.It is a neurotoxic - organochlorine insecticide.It is an endocrine disruptor & is highly toxic.Banned in…

1. TY-PAN-0597(2) Date of preparation: July 2013FOR HEALTHCARE PROFESSIONALS ONLY TYSABRI (natalizumab) Benefit/Risk Update & PML Risk Stratification 2. TY-PAN-0597(2)…

1. Tysabri (natalizumab) Benefit/Risk Update & PML Risk StratificationFOR HEALTHCARE PROFESSIONALS ONLYTY-PAN-0597(8) Date of preparation: January 2014 2. Benefit…

1. TYSABRI (natalizumab) Benefit/Risk Update & PML Risk StratificationFOR HEALTHCARE PROFESSIONALS ONLYTY-PAN-0597(6) Date of preparation: November 2013 2. Benefit…

1. TYSABRI (natalizumab) Benefit/Risk Update & PML Risk StratificationFOR HEALTHCARE PROFESSIONALS ONLYTY-PAN-0597(4) Date of preparation: September 2013 2. This…

1. TY-PAN-0597(1) Date of preparation: June 2013FOR HEALTHCARE PROFESSIONALS ONLY TYSABRI (natalizumab) Benefit/Risk Update & PML Risk Stratification 2. TY-PAN-0597(1)…